Refinement and Psychometric Evaluation of the Impact of Cancer Scale
Open Access
- 5 November 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 100 (21), 1530-1541
- https://doi.org/10.1093/jnci/djn340
Abstract
Instruments are needed to measure the influence of cancer on quality of life in the expanding population of long-term cancer survivors. We conducted refinement and psychometric evaluation of the Impact of Cancer (IOC) scale by use of data from a large sample of long-term breast cancer survivors and developed an instrument, the Impact of Cancer version 2 (IOCv2), to measure quality of life outcomes. Questionnaires including 81 potential IOC scale items, the Center for Epidemiologic Studies-Depression (CES-D) scale, and the Breast Cancer Prevention Trial (BCPT) symptom scales, as well as demographic, treatment, and medical information, were completed by 1188 disease-free breast cancer survivors 5–10 years after diagnosis. We used exploratory factor analysis to identify scales and assessed reproducibility by split-sample cross-validation. Higher-order scales were extracted and all scales were evaluated for internal consistency and construct and concurrent validity. The analysis yielded a factor structure relating IOC items to psychosocial impact domains that exhibited high factor loadings (factor–item correlations of 0.59–0.94), high internal consistency (Cronbach’s α statistics of 0.76–0.89), and a total congruence of 0.98 across the split samples. The Impact of Cancer version 2 (IOCv2) scales consist of a Positive Impact Summary scale with four subscales (Altruism and Empathy, Health Awareness, Meaning of Cancer, and Positive Self-Evaluation), a Negative Impact Summary scale with four subscales (Appearance Concerns, Body Change Concerns, Life Interferences, and Worry), and subscales for Employment and Relationship Concerns. Patterns of association between IOCv2 scale scores and CES-D and BCPT scores indicated good concurrent validity. Patterns of associations between IOCv2 scale scores and demographic, medical, and treatment characteristics indicated good construct validity. The IOCv2 scales provide a validated tool for measuring the impact of cancer on quality of life in long-term cancer survivors.Keywords
This publication has 50 references indexed in Scilit:
- Post-Traumatic Stress Outcomes in Non-Hodgkin's Lymphoma SurvivorsJournal of Clinical Oncology, 2008
- The health-related quality of life of long-term survivors of melanoma treated with isolated limb perfusionEuropean Journal of Surgical Oncology, 2007
- Sexual morbidity in very long term survivors of vaginal and cervical cancer: A comparison to national normsGynecologic Oncology, 2007
- Questionnaire discrimination: (re)-introducing coefficient δBMC Medical Research Methodology, 2007
- Assessment of Survivor Concerns (ASC): A newly proposed brief questionnaireHealth and Quality of Life Outcomes, 2007
- The MOS 36-Item Short-Form Health Survey (SF-36)Medical Care, 1993
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- The CES-D ScaleApplied Psychological Measurement, 1977
- The Scree Test For The Number Of FactorsMultivariate Behavioral Research, 1966
- Coefficient alpha and the internal structure of testsPsychometrika, 1951